系统性硬化症中升高的互白素-11和疾病发病过程中的作用
Thomas Steadman1, Steven O'Reilly1
1Biosciences, Durham University, Durham, UK.
The Journal of dermatology
|June 9, 2023
概括
在早期全身性硬化症 (SSc) 患者中,特别是那些患有肺部疾病的患者中,介质蛋白-11 (IL-11) 的含量升高. 此外,IL-11还会触发皮肤细胞中IL-33的释放,这表明它在SSc的病原发生过程中发挥了作用.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 纤维化研究 纤维化研究
背景情况:
- 系统性硬化症 (SSc) 是一种自身免疫性疾病,其特征是炎症,异常的细胞因子表达和纤维化.
- 互乐金-11 (IL-11) 是一种由TGF-β1上调的益菌性细胞因子,有助于多个器官的纤维化.
研究的目的:
- 在早期扩散性SSc患者中量化血清IL-11水平.
- 调查IL-11是否调节皮肤纤维细胞中的警报蛋白IL-33.
主要方法:
- 血清IL-11水平使用ELISA测量早期扩散SSc患者和健康对照.
- 皮肤纤维细胞被培养并用IL-11进行治疗;IL-33的释放被ELISA在不同的时间点定量.
主要成果:
- 在早期扩散性SSc患者中观察到血清IL-11的升高,在间歇性肺病 (ILD) 患者中水平更高.
- 在体外,IL-11显著诱导了IL-33在皮肤纤维细胞的早期释放,但不是晚期释放.
结论:
- 早期扩散性SSc中的IL-11升高,特别是ILD,表明它可能是SSc中的ILD的潜在生物标志物.
- IL-11对IL-33的诱导表明早期的炎症反应,而长期暴露可能会促进SSc中的纤维化.
相关概念视频
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Inflammatory Bowel Disease II: Crohn's Disease
303
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
303
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177


